PWPeng Wu

Peng Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peng Wu has a total of 78 co-authors. Here are the top co-authors by number of shared publications:

  • Wei Liu

    Department of Orthopedics, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China

    9 shared publications
  • Ziheng Bu

    Department of Orthopedics, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China

    8 shared publications
  • Jianing Yu

    Department of Orthopedics, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China

    7 shared publications
  • Junchao Huang

    Department of Orthopedics, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China

    7 shared publications
  • Jianhai Hu

    Department of Orthopedics Shanghai Tenth People's Hospital School of Medicine Tongji University Shanghai 200072 China

    5 shared publications
  • Zheng Zhou

    Department of Orthopedics Shanghai Tenth People's Hospital School of Medicine Tongji University Shanghai 200072 China

    5 shared publications

Latest Publications

  • Open Access

    Multimodal hydrogel modulation of extracellular vesicle cargo to arrest post-traumatic osteoarthritis in murine models

    by Xudong Zhang, Wei Zhu, Huajun Wang, Yingjie Wang, Ziheng Bu, Wei Liu, Junchao Huang, Jiawei Mei, Quan Liu, Jiachang Hong, et al.

    Effective prophylactic interventions for exercise-induced joint damage and preclinical osteoarthritis remain elusive, as abnormal mechanical loading drives pathology through a dual pyroptotic loop between chondrocytes and macrophages. We present PMUC, a mechano-responsive lubricating hydrogel engineered for graded joint protection and repair. Mimicking native lubrication, intra-articular PMUC forms a persistent hydration layer that dissipates mechanical stress. Under pathological load, stress-induced reactive oxygen species trigger mannose and nanocomplex release. This cascade activates the hexosamine biosynthetic pathway, suppressing Caspase-3/GSDME-mediated chondrocyte pyroptosis while concurrently reprogramming macrophage-derived extracellular vesicles. Enriched with XIAP and OTULIN proteins, these in situ-generated extracellular vesicles act as intercellular messengers that disrupt the inflammatory cycle and facilitate matrix regeneration. In preclinical rat models of high-load exercise and post-traumatic OA, PMUC prevents cartilage erosion and achieves full regeneration with restored locomotion within eight weeks. Here we show that PMUC integrates adaptive lubrication with stress-triggered immune-metabolic modulation, offering a first‑in‑class strategy to protect joints and alleviate early OA.

  • Open Access

    Standardized Image‐Based Arthroscopic Technique for Hip Synovial Chondromatosis: Long‐Term Patient Outcomes

    by Jinxi An, Jianing Yu, Rongzhen Lin, Mingyue Fan, Ziheng Bu, Wei Zhu, Jiachang Hong, Wei Liu, Junchao Huang, Yongjun Hu, et al.

    Objective: Arthroscopic surgery is recommended for the treatment of hip synovial chondromatosis, as it allows patients to resume daily activities quickly and requires only a short rehabilitation period. Despite its advantages, there is currently no standardized protocol for arthroscopic hip synovectomy, and complete removal of intra‐articular loose bodies remains challenging. The objective of this study is to evaluate long‐term clinical outcomes of arthroscopic treatment for hip synovial chondromatosis using a standardized protocol based on clock‐face‐guided, imaging‐based lesion localization. Methods: A consecutive cohort of patients undergoing arthroscopic treatment and diagnosed with synovial chondromatosis between June 2016 and July 2019 was included in the study. All patients underwent preoperative imaging‐guided localization of loose bodies followed by arthroscopic removal performed by a single surgeon, with a minimum postoperative follow‐up of 30 months. Preoperative and postoperative assessments included standard radiographs (x‐ray), three‐dimensional computed tomography (3D‐CT), magnetic resonance imaging (MRI), intraoperative arthroscopic images, visual analog scale (VAS) for pain, range of motion (ROM), modified Harris Hip Score (mHHS), and International Hip Outcome Tool (iHOT‐12). The percentage of patients achieving the minimal clinically important difference (MCID) was calculated to summarize and compare differences in clinical outcomes. Results: Seventeen patients were enrolled, with a mean postoperative follow‐up duration of 71 months. No major complications were observed. Patients achieved weight‐bearing ambulation at a mean of 7 days postoperatively and were discharged at a median of 2.5 days (range: 1–3 days). PROs demonstrated significant improvements: VAS for pain decreased from 7.6 to 2.1, mHHS increased from 54.6 preoperatively to 89.4 postoperatively, and iHOT‐12 improved from 38.1 to 75.2 (all p < 0.001). At long‐term follow‐up, all patients met MCID thresholds for both mHHS and iHOT‐12 scores. Conclusion: Arthroscopic treatment using a standardized protocol can result in favorable long‐term clinical outcomes.

  • Open Access

    Treatment of heterotopic ossification via inhibiting the MMP-2/CDH5 axis through oral delivery of network pharmacology-predicted Chinese medicine

    by Junchao Huang, Jinxi An, Le He, Huajun Wang, Jiachang Hong, Ziheng Bu, Xudong Zhang, Wei Liu, Tingyu Wu, Seng Wang, et al.


  • Osteoimmune-regulative metal-organic framework nanomedicine for effective osteoporosis therapeutics

    by Shuwen Qiu, Penghao Ji, Yuemei Wang, Qiuyi Duan, Jiadie Yu, Mengqiang Luo, Peng Wu, Minfeng Huo, Jianlin Shi


  • Ultrasound-guided endoscopy for recalcitrant plantar fasciitis with calcaneal spurs: A safety-oriented surgical adjunct to minimize complications

    by Jinxi An, Wei Zhu, Fangjing Chen, Ziheng Bu, Peng Wu

    Purpose To investigate whether ultrasound-guided preoperative portal localization in a modified double–medial-portal endoscopic technique reduces postoperative complications while maintaining comparable clinical outcomes in patients with recalcitrant plantar fasciitis. Methods A retrospective study was performed on 62 patients suffering from stubborn plantar fasciitis with a calcaneal spur from January 2023 to August 2024. 32 patients had a traditional endoscopic partial release of the plantar fascia, whereas 30 patients underwent a modified release guided by ultrasound. Two medial portals were used by both the traditional and altered groups. Every patient was monitored for a minimum of 12 months. The clinical results for both groups were assessed using the Visual Analogue Scale (VAS), the American Orthopaedic Foot and Ankle Society (AOFAS) score, the medial longitudinal arch angle (MLAA), and the Arch Index (AI). Results Both groups showed significant improvements in VAS and AOFAS scores at one, six and 12 months postoperatively. No significant between-group differences were observed in pain relief, functional recovery, or foot structural parameters at any follow-up time point. The ultrasound-guided group demonstrated a significantly lower incidence of postoperative complications. Patient-reported satisfaction appeared to be higher in the ultrasound-guided group. Conclusion Ultrasound-guided modified double–medial-portal endoscopic surgery provides comparable clinical outcomes with fewer postoperative complications, suggesting a safety advantage rather than superior efficacy in recalcitrant plantar fasciitis.

  • Top Cited Papers
    Open Access

    Self‐Assembled Myricetin‐Arginine Conjugate Nanozymes for Targeted Suppression of Joint Inflammation and Osteoclastogenesis in Rheumatoid Arthritis

    by Jiachang Hong, Penghao Ji, Jinxi An, Junchao Huang, Ziheng Bu, Xudong Zhang, Wei Liu, Tingyu Wu, Sen Wang, Wei Zhu, et al.

    Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by synovial inflammation and progressive joint destruction driven by macrophage polarization and osteoclast activation. Current therapies lack lesion‐specificity and cause systemic side effects, highlighting the need for targeted treatment strategies. Here, we developed carrier‐free myricetin‐arginine conjugate nanozymes (MANZs) via a Mannich reaction‐mediated conjugation of l ‐arginine and myricetin, followed by self‐assembly driven by noncovalent interaction. The MANZs selectively target M1 macrophages via cationic amino acid transporter 2 (CAT2)‐mediated uptake, facilitating preferential accumulation in inflamed joints. MANZs exert multi‐modal therapeutic effects by scavenging reactive oxygen species (ROS), repolarizing M1 macrophages, and inhibiting osteoclast differentiation. In a collagen‐induced arthritis (CIA) mouse model, MANZs significantly alleviated joint swelling, synovitis, and bone erosion without systemic toxicity. This work establishes a promising paradigm for RA therapy by integrating cationic amino acids with natural polyphenols into a self‐assembled, target‐specific nanoplatform with high biocompatibility and translational potential.


  • Open Access

    Endoscopic plantar fascia release via dual medial deep fascia approach for refractory plantar fasciitis: an effective, safe, and rapid surgical approach

    by Jianing Yu, Jinxi An, Sen Wang, Wei Liu, Ziheng Bu, Junchao Huang, Peng Wang, Tao Zhu, Peng Wu, Min Zhu

    Objective: This study aims to evaluate the clinical efficacy of endoscopic plantar fascia release through the modified dual medial deep fascia approach for the treatment of refractory plantar fasciitis. Methods: A retrospective study was conducted involving 34 patients with refractory plantar fasciitis treated by endoscopic plantar fascia release through the modified dual medial deep fascia approach. Among them, 25 patients had concurrent calcaneal spurs. All patients were followed for a minimum of 12 months. Functional outcomes were assessed using the Visual Analogue Scale (VAS) and the American Orthopaedic Foot and Ankle Society (AOFAS) score, while structural evaluations included the Medial Longitudinal Arch Angle (MLAA), navicular tuberosity height-to-foot length ratio (NH/FL), and the Arch Index (AI). Differences between patients with and without calcaneal spurs were also analyzed. Results: All patients completed at least 12 months of follow-up, with primary wound healing in all cases. Two patients experienced transient plantar skin numbness and small toe abduction difficulty, which resolved within three months. The VAS score decreased significantly from 6.53 ± 1.19 preoperatively to 1.18 ± 0.76 postoperatively, and the AOFAS score improved from 52.41 ± 5.23 to 93.29 ± 3.91 (both P < 0.05), indicating statistical significance. However, changes in the MLAA, NH/FL and AI were not statistically significant. Apart from age differences (49.04 ± 4.41 vs. 34.56 ± 3.13), no significant differences in other scores were observed between the calcaneal spur group and the non-calcaneal spur group at the final follow-up. Moreover, compared to the methods reported in other studies, our study demonstrated a shorter operative time and superior pain and functional outcomes. Conclusion: The dual medial deep fascia approach for endoscopic plantar fascia release is a safe, quick, effective, and minimally invasive technique that yields favourable clinical outcomes. It has certain advantages compared to other techniques. The presence of calcaneal spurs does not impact postoperative outcomes.


  • Open Access

    Treatment of Denervated Muscle Atrophy by Injectable Dual‐Responsive Hydrogels Loaded with Extracellular Vesicles

    by Ziheng Bu, Jianxing Jing, Wei Liu, Zhen Fan, Junchao Huang, Zheng Zhou, Jianhai Hu, Jinxi An, Jiachang Hong, Jianing Yu, et al.

    Denervated muscle atrophy, a common outcome of nerve injury, often results in irreversible fibrosis due to the limited effectiveness of current therapeutic interventions. While extracellular vesicles (EVs) offer promise for treating muscle atrophy, their therapeutic potential is hindered by challenges in delivery and bioactivity within the complex microenvironment of the injury site. To address this issue, an injectable hydrogel is developed that is responsive to both ultrasound and pH, with inherent anti‐inflammatory and antioxidant properties, designed to improve the targeted delivery of stem cell‐derived EVs. This hydrogel system allows for controlled release of EVs from human umbilical cord mesenchymal stem cells (HUC‐MSCs), adapting to the specific conditions of the injury environment. In vivo studies using a rat model of nerve injury demonstrated that the EV‐loaded hydrogel (EVs@UR‐gel) significantly preserved muscle function. Six weeks post‐nerve reconstruction, treated rats exhibited muscle strength, circumference, and wet weight reaching 89.53 ± 0.96%, 76.02 ± 7.49%, and 88.0 ± 2.65% of healthy controls, respectively, alongside an improvement in the sciatic nerve index (−0.11 ± 0.09). This platform presents a novel therapeutic approach by maintaining EV bioactivity, enabling tunable release based on the disease state, and facilitating the restoration of muscle structure and function.


  • Open Access

    Extracellular matrix hydrogels with fibroblast growth factor 2 containing exosomes for reconstructing skin microstructures

    by Zheng Zhou, Ziheng Bu, Shiqiang Wang, Jianing Yu, Wei Liu, Junchao Huang, Jianhai Hu, Sudan Xu, Peng Wu

    Decellularized extracellular matrix hydrogel (ECM hydrogel), a natural material derived from normal tissue with unique biocompatibility properties, is widely used for tissue repair. However, there are still problems such as poor biological activity and insufficient antimicrobial property. To overcome these drawbacks, fibroblast growth factor 2 (FGF 2) containing exosome (exoFGF 2) was prepared to increase the biological activity. Furthermore, the antimicrobial capacity of ECM hydrogel was optimised by using copper ions as a ligand-bonded cross-linking agent. The decellularized extracellular matrix hydrogel, intricately cross-linked with copper ions through ligand bonds and loaded with FGF 2 containing exosome (exoFGF 2@ECM/Cu2+ hydrogel), has demonstrated exceptional biocompatibility and antimicrobial properties. In vitro, exoFGF 2@ECM/Cu2+ hydrogel effectively promoted cell proliferation, migration, antioxidant and inhibited bacterial growth. In vivo, the wound area of rat treated with exoFGF 2@ECM/Cu2+ hydrogels were significantly smaller than that of other groups at Day 5 (45.24% ± 3.15%), Day 10 (92.20% ± 2.31%) and Day 15 (95.22% ± 1.28%). Histological examination showed that exoFGF 2@ECM/Cu2+ hydrogels promoted angiogenesis and collagen deposition. Overall, this hydrogel has the potential to inhibit bacterial growth and effectively promote wound healing in a variety of clinical applications.